Article Details
Retrieved on: 2021-04-02 09:15:59
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The company's lead product candidate is Lenzilumab, a monoclonal antibody that targets and neutralizes human granulocyte-macrophage colony- ...
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here